Nadine H Abdallah

48PUBLICATIONS
94CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Sep 12, 2026
Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.

|Aug 25, 2026
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

|Jul 27, 2026
Predictors of post-transplant measurable residual disease negativity and impact on clinical outcomes in multiple myeloma.

|Jul 27, 2026
Self-Reported Geriatric Impairments and Treatment Toxicity in Older Patients with Multiple Myeloma-A Single Center Prospective Study.

|Jul 21, 2026
Cytogenetics-based clinical trajectories in patients with MRD negativity post autologous transplant for multiple myeloma.

|Jun 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

Pageof 8

Frequent Collaborators

39 joint publications

Shaji Kumar

34 joint publications

Angela Dispenzieri

33 joint publications

Morie Gertz

32 joint publications

Moritz Binder